120 related articles for article (PubMed ID: 1394820)
1. Combination chemotherapy for advanced urothelial-tract carcinoma.
Sahashi M; Ono Y; Matsuura O; Ohshima S; Fukushima M
Cancer Chemother Pharmacol; 1992; 30 Suppl():S59-62. PubMed ID: 1394820
[TBL] [Abstract][Full Text] [Related]
2. Three-drug combination chemotherapy for advanced urothelial tract carcinoma.
Ohshima S; Ono Y; Fujita T; Aso Y
Cancer Chemother Pharmacol; 1987; 20 Suppl():S20-3. PubMed ID: 2444354
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract.
Kotake T; Usami M; Miki T; Kuroda M; Obata K; Osafune M; Fujioka H; Takasugi Y
Cancer Chemother Pharmacol; 1983; 11 Suppl():S38-42. PubMed ID: 6685580
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy of cyclophosphamide, adriamycin and cisplatin in advanced urothelial cancer].
Nakagawa S; Nakao M; Toyoda K; Nukui M; Takada H; Ebisui K; Watanabe H; Furusawa T; Maegawa M; Kaiho H
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3071-7. PubMed ID: 3674892
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of urothelial tract tumors.
Yagoda A
Cancer; 1987 Aug; 60(3 Suppl):574-85. PubMed ID: 3297286
[TBL] [Abstract][Full Text] [Related]
6. A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract.
Citrin DL; Hogan TF; Davis TE
Cancer; 1983 Jan; 51(1):1-4. PubMed ID: 6681590
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of metastatic urothelial carcinoma].
Kihara K; Sakuramoto T; Washizuka M; Kawai T; Ogawa M
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2046-7. PubMed ID: 6892194
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
Sternberg CN; Yagoda A; Scher HI; Watson RC; Geller N; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N
Cancer; 1989 Dec; 64(12):2448-58. PubMed ID: 2819654
[TBL] [Abstract][Full Text] [Related]
9. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
McCaffrey JA; Hilton S; Mazumdar M; Sadan S; Heineman M; Hirsch J; Kelly WK; Scher HI; Bajorin DF
J Clin Oncol; 1997 Jun; 15(6):2449-55. PubMed ID: 9196161
[TBL] [Abstract][Full Text] [Related]
10. [Results of combination chemotherapy in advanced urothelial cancer].
Komatsubara S; Watanabe M; Kitamura Y; Sakata Y
Hinyokika Kiyo; 1988 Oct; 34(10):1697-702. PubMed ID: 3245518
[TBL] [Abstract][Full Text] [Related]
11. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
Konami T; Wakabayashi Y; Kim T; Ishida A; Arai Y; Konishi T; Pak K; Takeuchi H; Tomoyoshi T; Watanabe J
Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-based chemotherapy for the treatment of advanced transitional-cell carcinoma of the urinary tract--a preliminary report.
Lee MH; Chen MT; Chen KK; Lin AT; Lee YH; Lee LM; Chang YM; Chang LS; Liu JM; Hsieh RK
Cancer Chemother Pharmacol; 1992; 30 Suppl():S81-4. PubMed ID: 1394825
[TBL] [Abstract][Full Text] [Related]
13. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.
Sternberg CN; Yagoda A; Scher HI; Watson RC; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N; Weiselberg LR
J Urol; 1988 Mar; 139(3):461-9. PubMed ID: 3343727
[TBL] [Abstract][Full Text] [Related]
14. Phase III trial of the Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder.
Maru A; Akaza H; Isaka S; Koiso K; Kotake T; Machida T; Matsumura Y; Nakagami Y; Niijima T; Obata K
Cancer Chemother Pharmacol; 1987; 20 Suppl():S44-8. PubMed ID: 3311445
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy with methotrexate (MTX), vincristine (VCR), cisplatinum (CDDP), cyclophosphamide (CPM), adriamycin (ADM), and bleomycin (BLM); MVP-CAB in patients with advanced urothelial tract cancer].
Fujii A; Morishita S; Nakamura I; Oka Y; Ohshima H; Nagata H; Iwamoto T; Izumi T; Miyasaki Z; Ito N
Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):985-93. PubMed ID: 2460657
[No Abstract] [Full Text] [Related]
16. Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma.
Dodd PM; McCaffrey JA; Mazumdar M; Scher H; Vlamis V; Higgins G; Herr H; Bajorin DF
Cancer; 1999 Mar; 85(5):1145-50. PubMed ID: 10091800
[TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy with cisplatin, ifosfamide and adriamycin in patients with advanced transitional cell carcinoma of the urinary tract].
Yoshimoto J; Nasu Y; Akagi T; Obama T; Tsushima T; Ozaki Y; Matsumura Y; Ohmori H; Asahi T; Ohkita K
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1312-7. PubMed ID: 4039919
[TBL] [Abstract][Full Text] [Related]
18. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tract.
Veronesi A; Galligioni E; Lo Re G; Sorio R; Saracchini S; Francini M; Merlo A; Dal Bo V; Monfardini S
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1457-60. PubMed ID: 3595670
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin chemotherapy for advanced urothelial cancers.
Ogawa T; Gotoh A; Takenaka A; Hara I; Gohji K; Arakawa S; Matsumoto O; Kamidono S
Cancer Chemother Pharmacol; 1992; 30 Suppl():S66-71. PubMed ID: 1394822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
